Multiple myeloma associated with CD4+ large granular lymphocytic leukemia: a possible causal relationship.
Haran
Michal Z
MZ
Basous
Lucette
L
Berrebi
Alain
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000187:drug effects / Q000473:pathology; D015704:CD4 Antigens / Q000032:analysis*; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000737:chemistry / Q000473:pathology*; D045744:Cell Line, Tumor / Q000187:drug effects; D002999:Clone Cells / Q000737:chemistry / Q000473:pathology; D003131:Combined Modality Therapy; D017077:Culture Media, Conditioned / Q000494:pharmacology; D003520:Cyclophosphamide / Q000008:administration & dosage; D018450:Disease Progression; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000473:pathology; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000209:etiology* / Q000532:radiotherapy; D014411:Neoplastic Stem Cells / Q000737:chemistry / Q000473:pathology*; D010014:Osteolysis / Q000209:etiology; D010265:Paraproteinemias / Q000150:complications; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D015704:CD4 Antigens; D017077:Culture Media, Conditioned; D014750:Vincristine; D003520:Cyclophosphamide; D008558:Melphalan; D011241:Prednisone